Xenogen Corporation

Founded in 1998, Xenogen is the pioneer and leader in the field of biophotonic imaging. Xenogen's VivoVision Systems utilize biophotonic imaging and serve to expedite drug discovery and development, thereby minimizing up-front costs and significantly reducing the time to market for new therapies. Non-invasive in vivo biophotonic imaging illuminates biological processes taking place in a living mammal to track biological activity in real time, at the molecular level, and provides richer and higher quality in vivo data earlier in the drug discovery and development processes. Through VivoVision Solutions, Xenogen provides industry-leading genetic modification technologies that include in vivo biophotonic imaging and services to oversee the design and production of transgenic animal models. Xenogen offers a range of R&D program models, including oncology, angiogenesis, infectious disease, inflammation, immunology, and drug metabolism.
Xenogen’s VivoVision Biosciences has a long history of high quality design and production of genetic modifications for animal models through phenotypic characterization, pronuclear microinjection, and gene knockin/knockout mouse techniques and breeding services.

Contact Details: 860 Atlantic Avenue Alameda California 94501 United States of America Tel: (510) 291-6100 Fax: (510) 291-6196 Email: businessdev@xenogen.com WWW: www.xenogen.com/

Loading...

Recent Publications by Xenogen Corporation:
Bioluminescent imaging of bacterial biofilm infections in vivo. Whole body biophotonic imaging (BPI) is a technique that has contributed...	3rd July, 2008	Xenogen Corporation, ALameda, CA, USA.	Methods Mol Biol. 2008;431:225-39.
Bioluminescence imaging to evaluate infections and host response in vivo. The continued prospect of emerging pathogens and recent events including...	20th June, 2008	Xenogen Corporation, Alameda, CA, USA.	Methods Mol Biol. 2008;415:101-18. DOI Direct Link
An extensive phenotypic characterization of the hTNFalpha transgenic mice. BACKGROUND: Tumor necrosis factor alpha (TNFalpha) is implicated in a wide...	27th February, 2008	Caliper Discovery Alliances & Services (Xenogen Biosciences), 5 Cedar	BMC Physiol. 2007 Dec 10;7:13. DOI Direct Link
Three-dimensional reconstruction of in vivo bioluminescent sources based on multispectral imaging. A new method is described for obtaining a 3-D reconstruction of a...	12th July, 2007	Caliper Life Sciences, Xenogen Corporation, 2061 Challenger Drive,	J Biomed Opt. 2007 Mar-Apr;12(2):024007. DOI Direct Link
The contribution of endogenous opioids to food reward is dependent on sex and background strain. Complex behaviors such as those associated with reward to unconditioned...	16th March, 2007	Center for the Study of Weight Regulation, Oregon Health and Science	Neuroscience. 2007 Jan 5;144(1):17-25. Epub 2006 Oct 13. DOI Direct Link
→View more Xenogen Corporation research publications.

Press Releases on Xenogen Corporation:
Morphochem and Xenogen collaborate to develop novel drug candidates	1st March, 2003	Morphochem	Morphochem and Xenogen collaborate to develop novel drug candidates against bacterial biofilms Munich, Germany, and

Xenogen Corporation Patents:
US Patent No.	Title
6610503	Animal models for predicting sepsis mortality
6922246	Bottom fluorescence illumination assembly for an imaging apparatus
6964856	Animal models and methods for sepsis
7056728	Compositions and methods for use thereof in modifying the genomes of microorganisms
7090994	Methods of screening for introduction of DNA into a target cell
→View more Xenogen Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 402 times since April 2007, the link to the organisation's website has been followed 41 times

Recent Search Terms used to find this page: Xenogen Corporation and TNF-alpha mice | biofilm in vivo xenogen | patent xenogen | .

Search for more companies in Alameda

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Xenogen Corporation